Due to increasing demand, and rising cost pressure on the NHS we need a new model of care that puts patients at the center and bring diagnostics closer to where care is delivered.
An efficient POCT service is a key enabler to achieve this and will ultimately improve patient pathways and clinical outcomes.
Biomedical scientists are the key workforce in making sure POCT is a safe, high-quality extension to the laboratory-based pathology service. Quality, convenience and choice are the new pathology partnership that will bring added benefits to patient care.
Siemens Healthineers continues to invest in POCT technologies with the recent acquisition of Epocal Inc., including the epoc® Blood Analysis System, a handheld, wireless testing solution. This uniquely positions Siemens Healthineers to offer provide the right solution in the right setting from one partner for our customers.